Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.
作者信息
Bellone Matteo, Brevi Arianna, Bruzzì Stefania, Consonni Michela, De Santis Francesca, Di Lullo Giulia, Majorini Maria Teresa, Pastò Anna, Amadori Alberto, Bregni Marco, Di Nicola Massimo, Calabrò Luana, Ferrucci Pier Francesco, Proietti Enrico, Colombo Mario Paolo, Russo Vincenzo
机构信息
Unit of Cellular Immunology, IRCCS Ospedale San Raffaele, Milan, Italy.
Unit of Immuno-Biotherapy of Melanoma and Solid Tumors, IRCCS Ospedale San Raffaele, Milan, Italy.
出版信息
Cancer Immunol Immunother. 2020 Jun;69(6):1141-1151. doi: 10.1007/s00262-020-02502-1. Epub 2020 Feb 6.
Abstract
摘要
相似文献
1
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.癌症生物免疫疗法第十六届年度NIBIT（意大利肿瘤生物治疗网络）会议，2018年10月11日至13日，意大利米兰。
Cancer Immunol Immunother. 2020 Jun;69(6):1141-1151. doi: 10.1007/s00262-020-02502-1. Epub 2020 Feb 6.
2
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy.癌症生物免疫疗法第十七届 NIBIT（意大利肿瘤生物治疗网络）年度会议，2019 年 10 月 11 日至 13 日，意大利维罗纳
Cancer Immunol Immunother. 2022 Jul;71(7):1777-1786. doi: 10.1007/s00262-021-03104-1. Epub 2021 Nov 9.
3
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020.癌症生物免疫疗法第十八届年度NIBIT（意大利肿瘤生物治疗网络）会议，2020年10月15日至16日。
Cancer Immunol Immunother. 2022 Jul;71(7):1787-1794. doi: 10.1007/s00262-022-03145-0. Epub 2022 Jan 16.
4
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5-7, 2017.意大利肿瘤生物治疗网络（NIBIT）关于癌症生物免疫治疗的第十五次会议，意大利锡耶纳，2017年10月5日至7日。
Cancer Immunol Immunother. 2019 Jan;68(1):151-158. doi: 10.1007/s00262-018-2222-0. Epub 2018 Aug 9.
5
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer.意大利肿瘤生物治疗网络（NIBIT）第九届年会，意大利锡耶纳，2011年10月19日至22日：癌症免疫治疗的新视角
Cancer Immunol Immunother. 2012 Sep;61(9):1599-608. doi: 10.1007/s00262-012-1304-7. Epub 2012 Jun 27.
6
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT).意大利肿瘤生物治疗网络（NIBIT）的目标。
Cytokine Growth Factor Rev. 2017 Aug;36:1-3. doi: 10.1016/j.cytogfr.2017.06.004. Epub 2017 Jun 16.
7
The Italian Network for Tumor Biotherapy (NIBIT). Sharing visions, goals and efforts at European level.意大利肿瘤生物治疗网络（NIBIT）。在欧洲层面分享愿景、目标和努力。
Tumori. 2008 Mar-Apr;94(2):179-81. doi: 10.1177/030089160809400208.
8
"Cancer Bio-Immunotherapy in Siena": Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015.“锡耶纳的癌症生物免疫疗法”：意大利肿瘤生物治疗网络（NIBIT）第十三次会议，意大利锡耶纳，2015年10月8日至10日。
Cancer Immunol Immunother. 2016 Nov;65(11):1423-1431. doi: 10.1007/s00262-016-1899-1. Epub 2016 Sep 12.
9
Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.意大利肿瘤生物治疗网络（NIBIT）第八届年会，锡耶纳，2010年10月7日至9日。
Cancer Immunol Immunother. 2011 Jun;60(6):901-7. doi: 10.1007/s00262-011-1006-6. Epub 2011 Mar 24.
10
"Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014.“锡耶纳的癌症生物免疫疗法”：意大利肿瘤生物治疗网络（NIBIT）第十二次会议，2014年10月9日至11日于意大利锡耶纳召开
Cancer Immunol Immunother. 2016 Jan;65(1):119-26. doi: 10.1007/s00262-015-1699-z. Epub 2015 May 6.
本文引用的文献
1
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells.烟酰胺磷酸核糖转移酶作为动员髓源性抑制细胞的代谢门控。
Cancer Res. 2019 Apr 15;79(8):1938-1951. doi: 10.1158/0008-5472.CAN-18-1544. Epub 2019 Feb 18.
2
Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models.化疗在乳腺癌模型中诱导促转移细胞外囊泡。
Nat Cell Biol. 2019 Feb;21(2):190-202. doi: 10.1038/s41556-018-0256-3. Epub 2018 Dec 31.
3
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes.FLIP 在单核细胞中诱导免疫抑制功能和 NF-κB。
Nat Commun. 2018 Dec 5;9(1):5193. doi: 10.1038/s41467-018-07654-4.
4
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.通过转导单个白血病 B 细胞诱导嵌合抗原受体 T 细胞治疗的耐药性。
Nat Med. 2018 Oct;24(10):1499-1503. doi: 10.1038/s41591-018-0201-9. Epub 2018 Oct 1.
5
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.抗体 Fc/FcR 相互作用在巨噬细胞中作为 PD-1/PD-L1 阻断后非小细胞肺癌发生超进展性疾病的机制。
Clin Cancer Res. 2019 Feb 1;25(3):989-999. doi: 10.1158/1078-0432.CCR-18-1390. Epub 2018 Sep 11.
6
High-dimensional single cell analysis identifies stem-like cytotoxic CD8 T cells infiltrating human tumors.高维单细胞分析鉴定出浸润人类肿瘤的类干细胞细胞毒性 CD8 T 细胞。
J Exp Med. 2018 Oct 1;215(10):2520-2535. doi: 10.1084/jem.20180684. Epub 2018 Aug 28.
7
High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific Models of Metastatic Colorectal Cancer.高通量筛选转移性结直肠癌患者特异性模型的组合免疫疗法。
Cancer Res. 2018 Sep 1;78(17):5155-5163. doi: 10.1158/0008-5472.CAN-18-1126. Epub 2018 Jul 2.
8
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.髓细胞分泌的白细胞介素-23 驱动去势抵抗性前列腺癌。
Nature. 2018 Jul;559(7714):363-369. doi: 10.1038/s41586-018-0266-0. Epub 2018 Jun 27.
9
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.单核细胞衍生的白细胞介素-1 和白细胞介素-6 对于 CAR T 细胞引起的细胞因子释放综合征和神经毒性是有差异需求的。
Nat Med. 2018 Jun;24(6):739-748. doi: 10.1038/s41591-018-0036-4. Epub 2018 May 28.
10
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study.特利木单抗联合度伐鲁单抗治疗间皮瘤患者（NIBIT-MESO-1）：一项开放标签、非随机、Ⅱ期研究。
Lancet Respir Med. 2018 Jun;6(6):451-460. doi: 10.1016/S2213-2600(18)30151-6. Epub 2018 May 15.
Zotero 插件